AAG
BMY icon

Armstrong Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Armstrong Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$257K Buy
4,121
+112
+3% +$7.08K 0.02% 213
2026
Q2 		$231K Sell
4,009
-601
-13% -$34.5K 0.01% 230
2026
Q1 		$280K Buy
4,610
+8
+0.2% +$466 0.02% 199
2025
Q4 		$248K Sell
4,602
-589
-11% -$28.3K 0.02% 201
2025
Q3 		$234K Buy
5,191
+10
+0.2% +$467 0.02% 198
2025
Q2 		$240K Sell
5,181
-967
-16% -$47.5K 0.02% 182
2025
Q1 		$348K Hold
6,148
– – 0.03% 138
2024
Q4 		$348K Buy
6,148
+218
+4% +$12.2K 0.03% 138
2024
Q3 		$307K Sell
5,930
-1,996
-25% -$93.6K 0.03% 145
2024
Q2 		$329K Sell
7,926
-338
-4% -$15.1K 0.03% 134
2024
Q1 		$424K Hold
8,264
– – 0.04% 112
2023
Q4 		$424K Sell
8,264
-427
-5% -$22.4K 0.04% 112
2023
Q3 		$504K Buy
8,691
+415
+5% +$25.4K 0.06% 86
2023
Q2 		$529K Sell
8,276
-36
-0.4% -$2.41K 0.06% 86
2023
Q1 		$576K Buy
8,312
+2
+0% +$141 0.07% 79
2022
Q4 		$598K Buy
+8,310
New +$627K 0.08% 81

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 13.32% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Armstrong Advisory Group's BMY Position: Q3 2026 in Review

Armstrong Advisory Group increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q3 2026, buying an estimated $7.08K and bringing the position to 4,121 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #213.

Armstrong Advisory Group first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $598K in Q4 2022. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Armstrong Advisory Group held 4,121 shares of Bristol-Myers Squibb worth $257K as of Q3 2026.
  • Armstrong Advisory Group bought 112 Bristol-Myers Squibb shares in Q3 2026, an estimated $7.08K.
  • Bristol-Myers Squibb made up 0.02% of Armstrong Advisory Group's portfolio in Q3 2026, its #213 holding.
  • Armstrong Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
  • Armstrong Advisory Group's Bristol-Myers Squibb position peaked at $598K in Q4 2022.
  • 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.